|
|
||||||||
4 and ß2 Integrin-Dependent Eosinophil Accumulation in Rat Skin In Vivo: Delayed Generation of Eotaxin in Response to IL-41





*
Leukocyte Biology Centre, Biomedical Sciences Division, Imperial College School of Medicine, London, United Kingdom;
Leukosite Inc., Cambridge, MA 02142;
Department of Immunology, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan;
§
Department of Immunology, University of Liverpool, Liverpool, United Kingdom; and
¶
Biogen Inc., Cambridge, MA 02142
The CC chemokine eotaxin, originally purified from bronchoalveolar
lavage fluid of sensitized guinea pigs following allergen challenge, is
a potent eosinophil-selective chemoattractant. In the present study, we
have used 111In-eosinophils and human eotaxin to
characterize the profile of chemokine-induced eosinophil accumulation
in vivo in rat skin. Intradermally injected eotaxin caused a
dose-dependent accumulation of 111In-eosinophils. Time
course studies indicated that the response was rapid, since all the
accumulation occurred within the first 1 to 2 h of eotaxin
injection. The i.v. administration of anti-intercellular adhesion
molecule-1, anti-vascular cell adhesion molecule-1, or
anti-
4 integrin mAbs significantly inhibited the eosinophil
accumulation induced by 100 pmol of human eotaxin by 73, 43, and 67%,
respectively. Further, when 111In-eosinophils were
pretreated in vitro with anti-
4 integrin or
anti-ß2 integrin mAbs, or with a combination of both
mAbs, eotaxin-induced responses in vivo were reduced by 52, 49, and
68%, respectively. Eosinophil accumulation induced by intradermal
IL-4, but not that induced by TNF-
or leukotriene B4,
appeared to be mediated in part by endogenously generated eotaxin.
Anti-eotaxin Abs significantly inhibited (54%) the later phases
(2428 h) but not the early phase (04 h) of the response to IL-4.
This was consistent with eotaxin mRNA expression peaking at 18 h
after IL-4 injection. Our findings show that human eotaxin is a potent
inducer of eosinophil accumulation in vivo, this response being
dependent on
4 integrin/vascular cell adhesion
molecule-1 and ß2 integrin/intercellular adhesion
molecule-1 adhesion pathways. Further, the eosinophil accumulation in
response to IL-4 is partly mediated by endogenously generated eotaxin.
This article has been cited by other articles:
![]() |
W.-Q. Lai, H. H. Goh, Z. Bao, W. S. F. Wong, A. J. Melendez, and B. P. Leung The Role of Sphingosine Kinase in a Murine Model of Allergic Asthma J. Immunol., March 15, 2008; 180(6): 4323 - 4329. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Teixeira, A. Talvani, W. L. Tafuri, N. W. Lukacs, and P. G. Hellewell Eosinophil recruitment into sites of delayed-type hypersensitivity reactions in mice J. Leukoc. Biol., March 1, 2001; 69(3): 353 - 360. [Abstract] [Full Text] |
||||
![]() |
F. J. Culley, A. Brown, D. M. Conroy, I. Sabroe, D. I. Pritchard, and T. J. Williams Eotaxin Is Specifically Cleaved by Hookworm Metalloproteases Preventing Its Action In Vitro and In Vivo J. Immunol., December 1, 2000; 165(11): 6447 - 6453. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Y. Larbi, A. R. Allen, F. W. K. Tam, D. O. Haskard, R. R. Lobb, P. M. R. Silva, and S. Nourshargh VCAM-1 has a tissue-specific role in mediating interleukin-4-induced eosinophil accumulation in rat models: evidence for a dissociation between endothelial-cell VCAM-1 expression and a functional role in eosinophil migration Blood, November 15, 2000; 96(10): 3601 - 3609. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bandeira-Melo, P. T. Bozza, B. L. Diaz, R. S. B. Cordeiro, P. J. Jose, M. A. Martins, and C. N. Serhan Cutting Edge: Lipoxin (LX) A4 and Aspirin-Triggered 15-Epi-LXA4 Block Allergen-Induced Eosinophil Trafficking J. Immunol., March 1, 2000; 164(5): 2267 - 2271. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-F. Guo, P. A. Ward, J. A. Jordan, M. Huber-Lang, R. L. Warner, and M. M. Shi Eotaxin Expression in Sephadex-Induced Lung Injury in Rats Am. J. Pathol., December 1, 1999; 155(6): 2001 - 2008. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stellato, S. Matsukura, A. Fal, J. White, L. A. Beck, D. Proud, and R. P. Schleimer Differential Regulation of Epithelial-Derived C-C Chemokine Expression by IL-4 and the Glucocorticoid Budesonide J. Immunol., November 15, 1999; 163(10): 5624 - 5632. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ying, D. S. Robinson, Q. Meng, L. T. Barata, A. R. McEuen, M. G. Buckley, A. F. Walls, P. W. Askenase, and A. B. Kay C-C Chemokines in Allergen-Induced Late-Phase Cutaneous Responses in Atopic Subjects: Association of Eotaxin with Early 6-Hour Eosinophils, and of Eotaxin-2 and Monocyte Chemoattractant Protein-4 with the Later 24-Hour Tissue Eosinophilia, and Relationship to Basophils and Other C-C Chemokines (Monocyte Chemoattractant Protein-3 and RANTES) J. Immunol., October 1, 1999; 163(7): 3976 - 3984. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Hickey, D. N. Granger, and P. Kubes Molecular Mechanisms Underlying IL-4-Induced Leukocyte Recruitment In Vivo: A Critical Role for the {alpha}4 Integrin J. Immunol., September 15, 1999; 163(6): 3441 - 3448. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Shinkai, H. Yoshisue, M. Koike, E. Shoji, S. Nakagawa, A. Saito, T. Takeda, S. Imabeppu, Y. Kato, N. Hanai, et al. A Novel Human CC Chemokine, Eotaxin-3, Which Is Expressed in IL-4-Stimulated Vascular Endothelial Cells, Exhibits Potent Activity Toward Eosinophils J. Immunol., August 1, 1999; 163(3): 1602 - 1610. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Giembycz and M. A. Lindsay Pharmacology of the Eosinophil Pharmacol. Rev., June 1, 1999; 51(2): 213 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Jinquan, S. Quan, G. Feili, C. G. Larsen, and K. Thestrup-Pedersen Eotaxin Activates T Cells to Chemotaxis and Adhesion Only if Induced to Express CCR3 by IL-2 Together with IL-4 J. Immunol., April 1, 1999; 162(7): 4285 - 4292. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yang, L. Cohn, D.-H. Zhang, R. Homer, A. Ray, and P. Ray Essential Role of Nuclear Factor {kappa}B in the Induction of Eosinophilia in Allergic Airway Inflammation J. Exp. Med., November 2, 1998; 188(9): 1739 - 1750. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |